Cargando…

Hydroxychloroquine prescribing habits and impact of the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Kuraitis, Drew, Murina, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier on behalf of the American Academy of Dermatology, Inc. 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566695/ https://www.ncbi.nlm.nih.gov/pubmed/33075416 http://dx.doi.org/10.1016/j.jaad.2020.10.019

Ejemplares similares

Chaperone use among dermatology residents and attendings is influenced by gender
por: Kuraitis, Drew, et al.
Publicado: (2021)

Lip swelling with lymphangiectasia
por: Kuraitis, Drew, et al.
Publicado: (2021)

Outpatient hydroxychloroquine prescribing at a large academic health system during the COVID-19 pandemic
por: Ha, David R., et al.
Publicado: (2020)

Principles of ethical prescribing for self and others: hydroxychloroquine in the COVID-19 pandemic
por: Coombes, Ian, et al.
Publicado: (2020)

Characteristics of US Patients and Prescribers Using Hydroxychloroquine During the COVID-19 Pandemic
por: Rome, Benjamin N., et al.
Publicado: (2021)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
por: Emmanuel, Stip, et al.
Publicado: (2020)

Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19
por: Delaleu, Jérémie, et al.
Publicado: (2020)

Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020)

Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
por: Sun, Xiaoxuan, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

COVID-19 and hydroxychloroquine: Let the available data speak for themselves
por: Paliani, Ugo, et al.
Publicado: (2020)

Impact of COVID-19 on Advanced Cancer Patients’ Pain Care: Warning About Chloroquine and Hydroxychloroquine
por: Aminnejad, Reza, et al.
Publicado: (2021)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Letter to the editor: The effect of hydroxychloroquine on COVID-19
por: Demir, Canan, et al.
Publicado: (2022)

Analysis of hydroxychloroquine prescriptions for COVID‐19 in Japan
por: Watari, Takashi, et al.
Publicado: (2023)

Digital habits of pulmonary rehabilitation service-users following the COVID-19 pandemic
por: Polgar, Oliver, et al.
Publicado: (2022)

Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic
por: Brufsky, Adam
Publicado: (2020)

Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic
por: Gagneux-Brunon, Amandine, et al.
Publicado: (2021)

Prescription restrictions on hydroxychloroquine among the largest Florida pharmacy chains during the COVID-19 pandemic: An observational study
por: Hadeler, Edward, et al.
Publicado: (2020)

Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19
por: Gevers, S., et al.
Publicado: (2020)

Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
por: Rani, Seema, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on the Jordanian eating and nutritional habits
por: Khamees, Almu'atasim, et al.
Publicado: (2022)

Hydroxychloroquine shortage
por: Patel, J., et al.
Publicado: (2020)

Trends in Insulin Prescribing for Patients With Diabetes During the COVID-19 Pandemic in the US
por: Yunusa, Ismaeel, et al.
Publicado: (2021)

Is it Possible to Change Prescribing Habits?
Publicado: (2005)

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study
por: Painvin, Benoit, et al.
Publicado: (2020)

Smoking habits and risk of COVID-19
por: Rossato, Marco
Publicado: (2021)

Can we use hydroxychloroquine to treat COVID-19 now?
por: Chen, Jun, et al.
Publicado: (2021)

Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
por: Kulkarni, Chanda, et al.
Publicado: (2021)

The significance of correct dosing of hydroxychloroquine in clinical trials of COVID-19
por: Sadasivam, Balakrishnan, et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis and treatment of COVID-19 in health-care workers
por: Simova, I., et al.
Publicado: (2020)

Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic
por: Dowd, William N., et al.
Publicado: (2022)

COVID-19 pandemic’s impact on eating habits in Saudi Arabia
por: Alhusseini, Noara, et al.
Publicado: (2020)

Digital habits of PR service-users: Implications for home-based interventions during the COVID-19 pandemic
por: Polgar, Oliver, et al.
Publicado: (2020)

Hydroxychloroquine: is there a role in long COVID?
por: Wang, Samuel S. Y., et al.
Publicado: (2023)

Hydroxychloroquine in the prophylaxis of COVID 19: A survey of safety on the healthcare workers in India
por: Mukhopadhyay, Sandip, et al.
Publicado: (2021)

Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin
por: Chang, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_517nnp63k71r42tph9q755bnh6